NCT01220063View on ClinicalTrials.gov

RSHF in Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 19, 2007

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Metastatic Colorectal Cancer
Interventions
RADIATION

Radiation

10 Gy for 4 times (total 40 Gy)

DRUG

Irinotecan

40 mg/m² : Day 1 and day 8

Trial Locations (6)

33075

Hôpital Saint André, Bordeaux

44805

Centre René Gauducheau, Saint-Herblain

45100

Hôpital la Source, Orléans

69000

Centre hospitalier Lyon Sud, Lyon

59 000

Centre Oscar Lambret, Lille

69 000

Centre Léon Berard, Lyon

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT01220063 - RSHF in Colorectal Cancer | Biotech Hunter | Biotech Hunter